Results 61 to 70 of about 744 (148)

Determinants of the dissemination of economic, social and environmental information at the university level in the context of commitment to the Sustainable Development Goals

open access: yesSustainable Development, Volume 32, Issue 3, Page 1925-1939, June 2024.
Abstract In the context of universities' commitment to the Sustainable Development Goals (SDGs), the paper aims to analyse the factors that influence the degree of information disclosure related to the economic, social, and environmental (ESE) aspects of SDGs.
Jesús Mauricio Flórez‐Parra   +3 more
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients

open access: yesBlood, 2019
Atypical chronic myeloid leukemia (aCML) is a rare BCR-ABL1 negative clonal disorder, which belongs to the myelodysplastic/myeloproliferative group. This disease is characterized by recurrent somatic mutations in several genes including SETBP1, ASXL1 and ETNK1, as well as high genetic heterogeneity, thus posing a great therapeutic challenge.
Diletta Fontana   +14 more
openaire   +2 more sources

Introduction: special issue of selected papers of ACML 2012 [PDF]

open access: yesMachine Learning, 2013
Zhi-Hua Zhou   +4 more
openaire   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

C097 | MDS/MPN OTHER THAN CMML: AN ITALIAN COOPERATIVE STUDY

open access: yesHaematologica
Background: MDS/MPN syndromes include chronic myelomonocytic leukemia (CMML), MDS/MPN with neutrophilia or atypical chronic myeloid leukemia (aCML), MDS/MPN neoplasm with SF3B1 mutation and thrombocytosis (-SF3B1) and MDS/MPN not otherwise specified ...
L. Guarnera   +24 more
doaj  

Identification of risk factors in atypical chronic myeloid leukemia

open access: yesHaematologica, 2006
In the WHO classification atypical chronic myeloid leukemia (CML) has been considered as a new distinct clinical entity included in the category of mixed myeloproliferative/myelodysplastic disorders.
M Breccia   +5 more
doaj  

miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia

open access: yesScientific Reports
Morgana is a ubiquitous HSP90 co-chaperone protein coded by the CHORDC1 gene. Morgana heterozygous mice develop with age a myeloid malignancy resembling human atypical myeloid leukemia (aCML), now renamed MDS/MPN with neutrophilia.
Pietro Poggio   +18 more
doaj   +1 more source

Pharmacogenetic Profiling of Allogeneic Stem Cell Transplantation Patients: An Exploratory Descriptive Study

open access: yesHemato
Background/Objectives: Patients receiving allogeneic hematopoietic stem cell transplantation (alloHCT) for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are at high risk for severe disease and treatment-related complications and ...
Lea P. A. Timmann   +8 more
doaj   +1 more source

Abnormal chromatin clumping in leucocytes of Ph positive Chronic Myeloid Leukemia cases - extending the morphological spectrum

open access: yesIndian Journal of Pathology and Microbiology, 2008
The syndrome of abnormal chromatin clumping is largely a morphological entity characterized by exaggerated chromatin clumping seen in the neutrophils. According to the recent World Health Organization (WHO) classification, it is categorized as a variant ...
Adhya Amit   +4 more
doaj  

Home - About - Disclaimer - Privacy